Barclays’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,723,000
Closed -$87.7M 5417
2024
Q2
$87.7M Buy
1,723,000
+1,678,000
+3,729% +$91.9M 0.03% 432
2024
Q1
$2.44M Buy
+45,000
New +$2.35M ﹤0.01% 2400
2022
Q1
Sell
-200,000
Closed -$15M 5424
2021
Q4
$15M Buy
+200,000
New +$14M 0.01% 1067
2021
Q2
Sell
-2,500
Closed -$135K 5019
2021
Q1
$135K Sell
2,500
-295,300
-99% -$16.1M ﹤0.01% 3881
2020
Q4
$14.3M Hold
297,800
0.01% 985
2020
Q3
$11.7M Sell
297,800
-2,100
-0.7% -$76.5K 0.01% 969
2020
Q2
$9.63M Sell
299,900
-6,300
-2% -$219K 0.01% 985
2020
Q1
$10.4M Sell
306,200
-17,000
-5% -$680K 0.01% 966
2019
Q4
$15.5M Sell
323,200
-3,700
-1% -$179K 0.01% 1098
2019
Q3
$16.3M Buy
326,900
+317,900
+3,532% +$16.2M 0.01% 1000
2019
Q2
$482K Sell
9,000
-1,500
-14% -$78.3K ﹤0.01% 4354
2019
Q1
$554K Sell
10,500
-57,655
-85% -$3M ﹤0.01% 4019
2018
Q4
$3.2M Sell
68,155
-29,300
-30% -$1.53M ﹤0.01% 1945
2018
Q3
$5.62M Buy
97,455
+33,433
+52% +$1.85M ﹤0.01% 1696
2018
Q2
$3.48M Sell
64,022
-70,545
-52% -$3.5M ﹤0.01% 2042
2018
Q1
$6.36M Buy
+134,567
New +$6.74M ﹤0.01% 1465

Other funds holding NTR

Barclays's NTR Position: Q1 2026 in Review

Barclays reduced its Nutrien (NTR) stake by 85% in Q1 2026, selling an estimated $11.6M and leaving 27,997 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2328.

Barclays first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $35.5M in Q2 2024. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Barclays held 27,997 shares of Nutrien worth $2.11M as of Q1 2026.
  • Barclays sold 162,236 Nutrien shares in Q1 2026, an estimated $11.6M.
  • Nutrien made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2328 holding.
  • Barclays first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
  • Barclays's Nutrien position peaked at $35.5M in Q2 2024.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.